Positively Aware Atripla

Atripla

efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF)

Recommended initial regimen in certain clinical situations
Single-Tablet Regimen

Standard Dose

One tablet once daily on an empty stomach, preferably at bedtime (food increases the risk of central nervous system, or CNS, toxicities). Tablet contains 600 mg of the NNRTI efavirenz plus 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate (TDF).

For adults and children 12 years of age and older weighing at least 88 pounds (40 kg).

Take missed dose as soon as possible, unless it is closer to the time of your next dose. Do not double up on your next dose. Do not split or crush the tablet. Dose cannot be adjusted for people with kidney problems and Atripla should not be used in people with moderate or severe kidney or liver impairment.

A similar, but not exact, off-patent medication is available (see pages for Symfi and Symfi Lo, EFV/3TC/TDF).

Manufacturer

Bristol-Myers Squibb
bms.com
atripla.com
(800) 321-1335

Gilead Sciences, Inc.
gilead.com
(800) GILEAD-5 (445–3235)

AWP

$3,266.88/month

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information

Doctor Comments

Activist Comments